Inside Doctronic’s experiment to allow AI to refill prescriptionsnews2026-01-08T13:00:33+00:00January 8th, 2026|Endpoints News|
Obesity biotech Alveus gains $160M for push into MariTide’s backyardnews2026-01-08T12:30:18+00:00January 8th, 2026|Endpoints News|
Parabilis gets $305M to tackle ‘undruggable’ proteinsnews2026-01-08T12:00:42+00:00January 8th, 2026|Endpoints News|
Vizgen raises $48M for push in spatial biology and multiomics toolsnews2026-01-08T12:00:41+00:00January 8th, 2026|Endpoints News|
French biotech Enodia gets €20.7M aided by Pfizer for protein degrader worknews2026-01-08T11:30:23+00:00January 8th, 2026|Endpoints News|
Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series Cnews2026-01-08T11:30:10+00:00January 8th, 2026|Endpoints News|
Diagonal Therapeutics secures $125M in Series B co-led by Sanofi Venturesnews2026-01-08T11:30:00+00:00January 8th, 2026|Endpoints News|
Former Genentech leaders’ protein degrader startup EpiBiologics nets $107Mnews2026-01-08T11:00:33+00:00January 8th, 2026|Endpoints News|
Poplar Therapeutics gets $50M Series A for immunology ambitionsnews2026-01-07T14:45:13+00:00January 7th, 2026|Endpoints News|
Soley emerges with $200M Series C and broad pipeline for ‘stress clock’news2026-01-07T11:30:08+00:00January 7th, 2026|Endpoints News|
